Psychostimulants: Basic and Clinical Pharmacology.

Area of Science:

• Neuroscience
• Pharmacology
• Addiction Research

Background:

• Substance use disorder, particularly psychostimulant abuse, imposes a substantial global socioeconomic burden.
• Psychostimulants encompass diverse chemical classes and affect the brain's reward system, leading to neuroplastic changes.
• Addiction involves alterations in neurotransmitter systems, including dopaminergic, glutamatergic, serotonergic (5-HT-ergic), and gamma-aminobutyric acid (GABA).

Purpose of the Study:

• To review the pharmacological changes associated with psychostimulant use and abuse in humans and animals.
• To discuss the transition from psychostimulant use to abuse, focusing on amphetamines and cocaine.
• To explore basic science and clinical strategies for treating psychostimulant abuse.

Main Methods:

• Literature review of pharmacological changes in psychostimulant addiction.
• Analysis of neurochemical and neurobehavioral alterations.
• Examination of transition mechanisms from use to abuse.

Main Results:

• Psychostimulant use induces persistent neuroplastic and dysfunctional changes in brain structures regulating learning, memory, and inhibitory control.
• Neurotransmitter systems like dopamine, glutamate, serotonin, and GABA are significantly affected in psychostimulant addiction.
• Understanding these changes is crucial for developing effective treatment strategies.

Conclusions:

• Psychostimulant abuse leads to complex neurobiological adaptations.
• Further research into neurochemical pathways and behavioral transitions is essential for advancing treatment interventions.
• Integrated basic science and clinical approaches are needed to combat psychostimulant use disorder.